Gene · 26801
Papers1,424
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,424
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis. | Int J Mol Sci | 2023 | 37240449 | PubTator, text mining | PubMed |
| Circulating microRNAs for Early Diagnosis of Ovarian Cancer: A Systematic Review and Meta-Analysis. | Biomolecules | 2023 | 37238740 | PubTator, text mining | PubMed |
| Mir-183 functions as an oncogene via decreasing PTEN in breast cancer cells. | Sci Rep | 2023 | 37208413 | PubTator, text mining | PubMed |
| Local Inflammatory Mediators Involved in Neuropathic Pain. | Int J Mol Sci | 2023 | 37175520 | PubTator, text mining | PubMed |
| Identification of Exo-miRNAs: A Summary of the Efforts in Translational Studies Involving Triple-Negative Breast Cancer. | Cells | 2023 | 37174739 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Packaged miR-195-5p Sensitizes Melanoma to Targeted Therapy with Kinase Inhibitors. | Cells | 2023 | 37174717 | PubTator, text mining | PubMed |
| Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328. | Cancers (Basel) | 2023 | 37173903 | PubTator, text mining | PubMed |
| Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity. | J Exp Clin Cancer Res | 2023 | 37170152 | PubTator, text mining | PubMed |
| Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells. | Front Oncol | 2023 | 37139155 | PubTator, text mining | PubMed |
| Monocyte subpopulations display disease-specific miRNA signatures depending on the subform of Spondyloarthropathy. | Front Immunol | 2023 | 37138886 | PubTator, text mining | PubMed |
| A Mixture Method for Robust Detection HCV Early Diagnosis Biomarker with ML Approach and Molecular Docking. | Int J Mol Sci | 2023 | 37108370 | PubTator, text mining | PubMed |
| MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent. | Int J Mol Sci | 2023 | 37108073 | PubTator, text mining | PubMed |
| Single cell quantification of microRNA from small numbers of non-invasively sampled primary human cells. | Commun Biol | 2023 | 37100999 | PubTator, text mining | PubMed |
| Comparative Expression Profiling Reveals Molecular Markers Involved in the Progression of Cutaneous Melanoma towards Metastasis. | Int J Mol Sci | 2023 | 37047539 | PubTator, text mining | PubMed |
| miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma. | J Transl Med | 2023 | 37024879 | PubTator, text mining | PubMed |
| MicroRNAs: Potential Biomarkers of Disease Severity in Chronic Rhinosinusitis with Nasal Polyps. | Medicina (Kaunas) | 2023 | 36984551 | PubTator, text mining | PubMed |
| Effect of ZEB1 Associated with microRNAs on Tumor Stem Cells in Head and Neck Cancer. | Int J Mol Sci | 2023 | 36982993 | PubTator, text mining | PubMed |
| Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics? | Biomedicines | 2023 | 36979630 | PubTator, text mining | PubMed |
| The glycoprotein CD147 defines miRNA-enriched extracellular vesicles that derive from cancer cells. | J Extracell Vesicles | 2023 | 36973758 | PubTator, text mining | PubMed |
| Concise review: Current understanding of extracellular vesicles to treat neuropathic pain. | Front Aging Neurosci | 2023 | 36936505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26801/papers?page=4